Enterprise record

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:695ba9c5-e4b2-488d-a358-29f2957449d4Version: public-1As of: unavailable

26 published Claims4 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 30, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 29, 2026

    Supports 3 claims
    • Legal Name: Tarsus Pharmaceuticals, Inc. · Claim reviewed: Sep 29, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 29, 2026
    • Published Fact: US · Claim reviewed: Sep 29, 2026

  2. SEC DEF 14A 0001819790-26-000028

    sec def 14a · Source published: Apr 28, 2026 · Retrieved: Sep 13, 2026

    Supports 14 claims
    • Leadership Role: Bobak Azamian, M.D., Ph.D.: President, Chief Executive Officer and Chairman · Claim reviewed: Sep 29, 2026
    • Leadership Role: Andrew Goldberg, M.D.: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Bhaskar Chaudhuri, Ph.D.: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: David E.I. Pyott, MBA: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Katherine Goodrich, M.D.: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Wendy Yarno, MBA: Lead Independent Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: William J. Link, Ph.D.: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Aziz Mottiwala, MBA: Chief Commercial Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Bobak Azamian, M.D., Ph.D.: President and Chief Executive Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Bryan Wahl, M.D., J.D.: General Counsel and Secretary · Claim reviewed: Sep 29, 2026
    • Leadership Role: Dianne Whitfield, MSW: Chief Human Resources Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Elizabeth Yeu-Lin, M.D.: Chief Medical Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Jeffrey Farrow: Chief Financial Officer and Chief Strategy Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Seshadri Neervannan, Ph.D.: Chief Operating Officer · Claim reviewed: Sep 29, 2026

  3. DEF 14A tars-20260428.htm

    sec proxy · Source published: Apr 28, 2026 · Retrieved: Sep 2, 2026

    Supports 7 claims
    • Leadership Role: Andrew Goldberg: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Bhaskar Chaudhuri: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: David E.I. Pyott: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Katherine Goodrich: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Scott Morrison: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Wendy Yarno: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: William J. Link: Director · Claim reviewed: Sep 29, 2026

  4. TARS DEF 14A executive officers

    sec filing · Source published: Apr 28, 2026 · Retrieved: May 5, 2026

    Supports 2 claims
    • Leadership Role: Bobak Azamian: President, Chief Executive Officer, and Board Chairman · Claim reviewed: Sep 29, 2026
    • Leadership Role: Bryan Wahl: General Counsel and Secretary · Claim reviewed: Sep 29, 2026